Proactive Temperature Management: The Key to a More Resilient Pharma Supply Chain

A speaker at the LogiPharma conference presents on 'Reactive Excursion Intervention with Real-Time Temperature Data,' illustrating the importance of proactive temperature management for a resilient pharma supply chain.
At this year's LogiPharma Europe 2025 in Lyon, Anita Leposa, Key Account Manager at TSS, and Neil Malkin, Business Process Owner for Temperature Management at AstraZeneca, took the stage to discuss one of the most pressing challenges in the pharmaceutical supply chain: temperature excursions and their impact on medicine availability.
Photo: WBR/LogiPharma

With medicine shortages affecting nearly every hospital pharmacy in Europe, the industry must rethink how it manages and prevents supply disruptions. The discussion at LogiPharma focused on how real-time temperature monitoring is transforming logistics-reducing waste, improving efficiency, and ultimately ensuring that patients receive the medications they need, when they need them.

Medicine Shortages and Supply Chain Vulnerabilities

A recent report by the European Association of Hospital Pharmacists (EAHP) revealed that 95% of hospital pharmacists across Europe have reported medicine shortages, leading to delays in care (59%), suboptimal treatment (43%), and even cancellation of care (35%).

One of the key factors contributing to these shortages is temperature excursions-when pharmaceutical products are exposed to conditions outside their required temperature range. Each year, the pharma industry loses an estimated $20-30 billion due to failures in temperature-controlled logistics.

According to the World Health Organization (WHO), up to 50% of vaccines are wasted globally, with temperature excursions playing a significant role.

The consequences go beyond financial losses-supply chain inefficiencies directly impact patient health. If a shipment is delayed or compromised, it can mean the difference between a patient receiving life-saving treatment or going without it.

From Reactive to Proactive: The Role of Real-Time Temperature Monitoring

Historically, pharma logistics relied on passive temperature monitoring-tracking excursions only after they happened. This reactive approach often led to costly investigations, reshipping of products, and increased carbon emissions from expedited transport.

Now, with real-time temperature monitoring, companies can detect and address temperature issues as they happen, preventing costly spoilage and ensuring compliance with strict pharmaceutical regulations.

How It Works:

1. Each shipment is equipped with a temperature logger that records temperature data every 30 minutes, transmitting it in real time.

2. If a temperature deviation occurs, an alert is sent immediately to the TSS control tower.

3. To prevent false alarms, temperature changes near designated facilities are filtered out.

4. The freight partner is notified and asked to take corrective action. If no action is taken, a follow-up reminder is sent within an hour.

__wf_reserved_inherit
This system allows supply chain teams to intervene before a product becomes compromised, reducing waste and avoiding disruptions in medicine availability.

A Smarter, More Sustainable Future for Pharma Logistics

The shift toward real-time data and predictive analytics represents a major opportunity for the pharma industry. By embracing proactive monitoring, companies can:

  • Reduce product waste
  • Lower carbon emissions from emergency shipments
  • Improve supply chain efficiency and resilience
  • Ensure compliance with regulatory standards

Beyond financial and environmental benefits, the true impact of these advancements is on patients who rely on life-saving medicines. By optimizing cold chain logistics and preventing temperature excursions, the industry can ensure that critical treatments reach those who need them-safely and on time.

At TSS, we are committed to helping pharmaceutical companies build smarter, greener, and more resilient supply chains.

Want to learn more?

Let’s continue the conversation! Contact us today to find out more about the intervention process and explore how real-time monitoring can help secure your pharmaceutical supply chain.

Contact us >

You may also be interested in

Profile photo of Gustaf Rasin, new Chief Operations Officer at TSS.

TSS Welcomes Gustaf Rasin as New Chief Operations Officer

TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.
Read moreDownload Whitepaper
People seated at round tables in a conference room watching a presenter speak in front of a large screen displaying a pie chart.

Working Together to Make Clinical Trials Faster and Safer

TSS recently hosted the TSS User Forum 2025, bringing together leading experts from the life science industry to discuss how automation, data integrity, and collaboration can make temperature management in clinical trials faster, safer, and more reliable.
Read moreDownload Whitepaper
An inspector in a hard hat examining a brick wall, with text overlay emphasizing stress-free audit inspection readiness.

The GCSG 2022 European Knowledge Forum is coming up, and we will be there.

This year several events are returning to in-person meetings, and the GCSG (Global Clinical Supply Group) European Knowledge Forum is one of them. GCSG is committed to making the world of clinical supplies a little less complex and more accessible to future clinical supplies leaders. They strive to connect all of us to share best practices while providing access to valuable education and resources. As a member of the GCSG, TSS is looking forward to interesting discussions, presentations and showcases at this year´s forum taking place in Dubrovnik Oct 4th-6th.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.